Gastric Ulcers Market Trends, Size And Forecast To 2024-2033

The gastric ulcers global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Gastric Ulcers Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size –
The gastric ulcers market size has grown strongly in recent years. It will grow from $4.07 billion in 2023 to $4.29 billion in 2024 at a compound annual growth rate (CAGR) of 5.3%.  The growth in the historic period can be attributed to the rising prevalence of helicobacter pylori infections, increasing use of nonsteroidal anti-inflammatory drugs (NSAIDs), growing geriatric population globally, rising awareness campaigns for gastric ulcer prevention and increasing incidence of stress-related disorders.

The gastric ulcers market size is expected to see strong growth in the next few years. It will grow to $5.34 billion in 2028 at a compound annual growth rate (CAGR) of 5.6%.  The growth in the forecast period can be attributed to improvements in diagnostic techniques, adoption of unhealthy dietary habits, advancements in treatment options, including proton pump inhibitors (PPIs), aging population contributing to higher disease burden and expansion of healthcare infrastructure in emerging markets. Major trends in the forecast period include shift towards combination therapies for enhanced efficacy, growing preference for minimally invasive treatment procedures, integration of digital health solutions in disease management, rising demand for over-the-counter (OTC) ulcer medications and expansion of personalized medicine approaches in ulcer treatment.

Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/gastric-ulcers-global-market-report

Scope Of Gastric Ulcers Market
The Business Research Company’s reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Gastric Ulcers Market Overview

Market Drivers –
The increasing geriatric population is expected to propel the growth of the gastric ulcers market going forward. The geriatric population refers to individuals typically aged 65 years and older, characterized by specific health considerations related to aging. The increase in the geriatric population is due to advancements in healthcare, leading to longer life expectancy and declining birth rates in many regions globally. Gastric ulcers are common in the geriatric population due to increased use of NSAIDs and decreased mucosal protection, often leading to higher risks of complications. For instance, in October 2022, according to the World Health Organization, a Switzerland-based health agency, the global population aged 60 years and over is set to increase significantly, from 1 billion in 2020 to 1.4 billion by 2030, reaching 2.1 billion by 2050. Concurrently, the number of individuals aged 80 or older is expected to triple, reaching 426 million by 2050. Therefore, the increasing geriatric population is driving the growth of the gastric ulcers market.

Market Trends –
Major companies operating in the gastric ulcer market are focusing on developing innovative drugs, such as generic versions of capsules, to serve customers better. Generic capsule refers to a medication in capsule form that contains generic active ingredients such as proton pump inhibitors (PPIs), H2-receptor antagonists, or other ulcer-healing agents used to treat or manage gastric ulcers. For instance, in September 2021, Dr. Reddy’s Laboratories, an India-based pharmaceutical company, launched a generic version of the stomach ulcer drug Librax (Chlordiazepoxide Hydrochloride and Clidinium Bromide capsules) in the US market. This move expands the range of pharmaceutical products available to patients in the US. It offers a more cost-effective option for treating stomach ulcers and related gastrointestinal conditions than the branded drug Librax.

The gastric ulcers market covered in this report is segmented –
1) By Drug Class: Proton Pump Inhibitors (PPI), H2 Antagonists, Antacids, Antibiotics, Cytoprotective Agents, Other Drug Classes
2) By Diagnosis: Stool Test, Endoscopy, Imaging Tests, Computed Tomography (CT ) Scan, X-ray, Blood Tests, Other Diagnosis
3) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations
4)  By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End Users

Get an inside scoop of the gastric ulcers market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=17160&type=smp

Regional Insights –
North America was the largest region in the gastric ulcers market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric ulcers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Key Companies –
Major companies operating in the gastric ulcers market are  Pfizer Inc., Merck & Co Inc., AbbVie Inc., Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Co. Ltd, Amgen Inc., Boehringer Ingelheim, Viatris Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd, Cadila Pharmaceuticals, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Lupin Limited , Yuhan Corporation, Daewoong Pharmaceutical Co. Ltd, Cadila Healthcare Ltd, Novitium Pharma LLC

Table of Contents

1. Executive Summary
2. Gastric Ulcers Market Report Structure
3. Gastric Ulcers Market Trends And Strategies
4. Gastric Ulcers Market – Macro Economic Scenario
5. Gastric Ulcers Market Size And Growth
…..

32. Global Gastric Ulcers Market Competitive Benchmarking
33. Global Gastric Ulcers Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Gastric Ulcers Market
35. Gastric Ulcers Market Future Outlook and Potential Analysis
36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model